On January 10, 2013, the Patient-Centered Outcomes Research Institute (PCORI) awarded a $1.9 million dollar grant to Arbor Research Collaborative for Health for a study called “Empowering Patients on Choices for Renal Replacement Therapy” (EPOCH-RRT) to study the selection of dialysis modality for kidney failure. Francesca Tentori, MD, a nephrologist and research scientist at Arbor Research, was the lead on the project. The initiative focused on "filling the knowledge gap that currently exists regarding patients’ priorities around dialysis modality" and was intended to gain "meaningful information for patients and caregivers."There was one problem: the research was proposed to focus solely on in-center hemodialysis and peritoneal dialysis, the two types of dialysis that are the most commonly used—and, coincidentally—the most profitable to use, as well. In the spirit of full disclosure, the study itself did mention other dialysis options, such as hemodialysis done at home (home HD), kidney transplant, and conservative management (no dialysis or transplant), and even provided a very limited list of resources.However, the new, "Choosing Dialysis" Arbor decision tool based on the EPOCH-RRT study, still only provides for two treatment options: in-center HD and peritoneal dialysis. Home Dialyzors United (HDU), the only dialysis patient group dedicated exclusively to peritoneal dialysis and home hemodialysis, has a mission to inform, inspire, and advocate for the home dialysis community. When we learned that Arbor Research was testing a "decision aid" that excluded home HD, including nocturnal and short daily HD, we vigorously opposed releasing this tool to the public without including ALL available treatments.
HDU feels strongly that patients deserve the right that the Conditions for Coverage grant to: "Be informed about all treatment modalities and settings, including but not limited to, transplantation, home dialysis modalities (home hemodialysis, intermittent peritoneal dialysis, continuous ambulatory peritoneal dialysis,and continuous cycling peritoneal dialysis) and in-facility hemodialysis." And, yet Arbor requested—and PCORI funded—a study that directly contradicts this mandate.